Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Right Ventricular Heart Failure
100%
Personalized Healthcare
100%
Long Non-coding RNA (LncRNA)
100%
Socioeconomic Burden
15%
Luxembourg
15%
Warsaw
7%
Treatment Modification
7%
Heart Failure
7%
Health Institutes
7%
Cardiovascular Disease
7%
Failure Development
7%
Therapeutic Biomarkers
7%
Preventable Diseases
7%
Patient-centered
7%
Risk Stratification
7%
Treatment Monitoring
7%
Poland
7%
Patient Monitoring
7%
Putative Drug Targets
7%
Patient Management
7%
Frequent Monitoring
7%
Patient Risk
7%
Centrum
7%
Biomarker Potential
7%
Molecular Mechanism
7%
Functional Biomarkers
7%
Disease Burden
7%
Patient Identification
7%
Right Ventricular Hypertrophy
7%
High Risk
7%
Medical Problems
7%
Novel Treatments
7%
Patient Outcomes
7%
Expected Impact
7%
Pulmonary Arterial Hypertension
7%
Functional Role
7%
Treatment Intensification
7%
Scientific Impact
7%
Left Ventricular Heart Failure
7%
Translational Research
7%
Clinical Option
7%
Medicine and Dentistry
Heart Right Ventricle Failure
100%
Long Untranslated RNA
100%
Biological Marker
23%
Diseases
23%
Patient Monitoring
15%
Congestive Heart Failure
7%
Clinician
7%
Right Ventricular Hypertrophy
7%
Cardiovascular Disease
7%
Heart Left Ventricle Failure
7%
Pulmonary Hypertension
7%
Translational Research
7%
Risk Stratification
7%
Patient Care
7%
Therapeutic Target
7%
Pharmacology, Toxicology and Pharmaceutical Science
Heart Right Ventricle Failure
100%
Long Untranslated RNA
100%
Biological Marker
23%
Diseases
23%
Heart Right Ventricle Hypertrophy
7%
Heart Left Ventricle Failure
7%
Pulmonary Hypertension
7%
Cardiovascular Disease
7%
Congestive Heart Failure
7%